PIMA541718
Palivizumab Recombinant Human Monoclonal Antibody, Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIMA541718-Each-of-1 | In Stock | ₹ 45,646.26 |
PIMA541718 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 45,646.26
GST (18%): ₹ 8,216.327
Total Price: ₹ 53,862.587
Antigen
Palivizumab
Classification
Recombinant Monoclonal
Conjugate
Unconjugated
Gene Alias
MEDI-493; Synagis
Immunogen
Respiratory syncytial virus- RSV
Quantity
100 μg
Primary or Secondary
Primary
Content And Storage
-20° C, Avoid Freeze/Thaw Cycles
Form
Liquid
Target Molecule
Chemical
Applications
ELISA, SDS-Page
Concentration
3.3 mg/mL
Formulation
PBS with no preservative; pH 7.4
Host Species
Human
Purification Method
Protein A
Regulatory Status
RUO
Target Species
Chemical
Product Type
Antibody
Isotype
IgG1 κ
Related Products
Description
- Endotoxin level < 0.01EU/μg by LAL method Use a manual defrost freezer and avoid repeated freeze thaw cycles
- Store at 2 to 8 °C for one week
- Store at -20 to -80 °C for twelve months from the date of receipt
- Palivizumab with trade name Synagis, is an FDA-approved drug for the prevention of respiratory syncytial virus (RSV) infections
- It is a recombinant humanized IgG1 kappa isotype monoclonal antibody
- Palivizumab binds the RSV envelope fusion protein (RSV F) on the surface of the virus and blocking a critical step in the membrane fusion process.
Compare Similar Items
Show Difference
Antigen: Palivizumab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: MEDI-493; Synagis
Immunogen: Respiratory syncytial virus- RSV
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA, SDS-Page
Concentration: 3.3 mg/mL
Formulation: PBS with no preservative; pH 7.4
Host Species: Human
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: IgG1 κ
Antigen:
Palivizumab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
MEDI-493; Synagis
Immunogen:
Respiratory syncytial virus- RSV
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA, SDS-Page
Concentration:
3.3 mg/mL
Formulation:
PBS with no preservative; pH 7.4
Host Species:
Human
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
IgG1 κ
Antigen: Sevirumab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: EV2 7; HCMV; MSL 109; SDZ MSL 109
Immunogen: Human herpesvirus 6 HCMV
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA, SDS-Page
Concentration: 1.94 mg/mL
Formulation: PBS with no preservative; pH 7.5
Host Species: Human
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: IgG1 κ
Antigen:
Sevirumab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
EV2 7; HCMV; MSL 109; SDZ MSL 109
Immunogen:
Human herpesvirus 6 HCMV
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA, SDS-Page
Concentration:
1.94 mg/mL
Formulation:
PBS with no preservative; pH 7.5
Host Species:
Human
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
IgG1 κ
Antigen: Ranibizumab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: Fab-12 variant Y0317; Lucentis; RhuFab
Immunogen: Human VEGFA
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA, SDS-Page
Concentration: 1.89 mg/mL
Formulation: PBS with no preservative; pH 7.4
Host Species: Human
Purification Method: Protein L
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: IgG1 F(ab) κ
Antigen:
Ranibizumab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
Fab-12 variant Y0317; Lucentis; RhuFab
Immunogen:
Human VEGFA
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA, SDS-Page
Concentration:
1.89 mg/mL
Formulation:
PBS with no preservative; pH 7.4
Host Species:
Human
Purification Method:
Protein L
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
IgG1 F(ab) κ
Antigen: Pascolizumab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: SB-240683
Immunogen: Human IL4
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA, SDS-Page
Concentration: 2.15 mg/mL
Formulation: PBS with no preservative; pH 7.5
Host Species: Human
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: IgG1 κ
Antigen:
Pascolizumab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
SB-240683
Immunogen:
Human IL4
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA, SDS-Page
Concentration:
2.15 mg/mL
Formulation:
PBS with no preservative; pH 7.5
Host Species:
Human
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
IgG1 κ